DiGeorge Anomaly
5
0
0
4
Key Insights
Highlights
Success Rate
80% trial completion
Treatment Research
15 treatments under study, led by Cyclosporine
Related Conditions
Often studied with 5 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
20.0%
1 terminated out of 5 trials
80.0%
-6.6% vs benchmark
0%
0 trials in Phase 3/4
75%
3 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (5)
Thymus Transplantation Safety-Efficacy
Thymus Transplantation With Immunosuppression
Serum-Free Thymus Transplantation in DiGeorge Anomaly
Thymus Transplantation Dose in DiGeorge #932
Phase I/II Thymus Transplantation With Immunosuppression #950
Research Network
Common Treatments
- Cyclosporine1
- Cultured Thymus Tissue Implantation With Parathyroid Transplantation1
- Cultured Thymus Tissue Implantation Ctti1
- Cultured Thymus Tissue Implantation And Parental Parathyroid Transplantation1
- Thymus Tissue For Transplantation1
Active Sponsors
- National Institutes of Health (NIH)5
- Sumitomo Pharma Switzerland GmbH5
- National Institute of Allergy and Infectious Diseases (NIAID)5
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)5
Top Investigators
Duke University Medical Center, Pediatrics, Allergy & Immunology
Duke University Medical Center, Pediatrics, Allergy & Immunology
Duke University Medical Center, Pediatrics, Allergy & Immunology
Related Conditions
- Complete Digeorge Anomaly4
- Complete Digeorge Syndrome4
- Digeorge Syndrome3
- Complete Atypical Digeorge Syndrome1
- Complete Atypical Digeorge Anomaly1